The Gates Foundation-hosted conference held in London on 30th January, ‘Uniting To Combat Tropical Diseases’, draws attention to devastating tropical illnesses that have been neglected for too long. However, the ambitious goals to eliminate or control ten neglected tropical diseases will only be...
2011 marks the ten-year anniversary of two events that have helped shape people’s ability in developing countries to access quality, affordable medical care. First, the signing of the Doha Declaration, in which governments affirmed the need to prioritise health over trade: access to affordable...
MSF response to unprecedented decision to cancel funding round of the Global Fund to Fight AIDS, TB and Malaria, taken at board meeting in Accra, Ghana, November 21-22, 2011 Because donor funding for global HIV/AIDS and the Global Fund has been declining, the Fund is in the most dire financial...
Latest UNAIDS treatment numbers show progress, but funding crunch is major threat The growing number of averted HIV/AIDS deaths according to data released by UNAIDS represents important progress, but the number of people put on treatment must increase dramatically in order to reap the benefits of...
Novartis will go before the Indian Supreme Court tomorrow in the latest attempt by the Swiss multinational pharmaceutical company to undermine a key public health safeguard in Indian patent law specifically designed to prevent drug companies from abusively patenting known medicines. If successful,...
Excluded countries should be ready to issue compulsory licences to access needed drugs An agreement announced today by pharmaceutical company Gilead to licence several HIV/AIDS drugs to the Medicines Patent Pool could improve access to medicines for patients, but excludes several countries with...
Funds and affordable drugs needed to turn target into treatment On the heels of new evidence that shows HIV treatment is also HIV prevention, governments meeting at a UN Summit on AIDS have taken a critical step by committing to reach 15 million people with HIV treatment by 2015 – but they must...
Latest Research Shows Expanded Treatment Could Turn AIDS Tide At a time when HIV treatment has proven to reduce HIV transmission by 96 percent, governments meeting for the UN Summit on AIDS must agree today to put nine million people on treatment over the next four years, despite strong opposition...
Licenses just agreed between three generic manufacturers and pharmaceutical company Tibotec, owned by Johnson & Johnson, will keep a promising new AIDS medicine out of the hands of many patients across the developing world, the international medical humanitarian organisation Médecins Sans...
Latest round of negotiations on sensitive intellectual property issues resumes tomorrow India should resist pressure from the European Union to accept, as part of a free trade agreement, harmful provisions that will have a major negative impact on access to affordable medicines, the international...
